{"id":3232,"date":"2026-01-23T18:34:42","date_gmt":"2026-01-23T18:34:42","guid":{"rendered":"https:\/\/www.finznest.com\/blog\/stocks-making-the-biggest-moves-midday-ftnt-mrna-intc-bhc\/"},"modified":"2026-01-23T18:34:42","modified_gmt":"2026-01-23T18:34:42","slug":"stocks-making-the-biggest-moves-midday-ftnt-mrna-intc-bhc","status":"publish","type":"post","link":"https:\/\/www.finznest.com\/blog\/stocks-making-the-biggest-moves-midday-ftnt-mrna-intc-bhc\/","title":{"rendered":"Stocks making the biggest moves midday: FTNT, MRNA, INTC, BHC"},"content":{"rendered":"<div>\n<div data-test=\"articleBody-2\" data-analytics=\"RegularArticle-articleBody-5-2\">\n<p><span hidden=\"\" aria-hidden=\"true\" class=\"ArticleBody-extraData\"><span hidden=\"\" aria-hidden=\"true\" class=\"ArticleBody-extraData\"><span hidden=\"\" aria-hidden=\"true\" class=\"xyz-data\">Check out the companies making headlines in midday trading. Fortinet \u2014 Shares jumped more than 7% after TD Cowen upgraded the cybersecurity stock to buy from hold, saying rising memory prices won&#8217;t hurt the company as much as some suspect. The firm&#8217;s $100 price target suggests 29% upside ahead. Bausch Health \u2014 The pharmaceutical stock fell 9% after one of its experimental treatments missed targets in a late-stage clinical trial. Bausch was working on a treatment for hepatic encephalopathy, a condition where toxins build up in the blood, hurting brain function, in patients with liver disease. Moderna \u2014 The biotech&#8217;s stock pulled back 6%, breaking a four-day win streak. The move follows CEO Stephane Bancel telling Bloomberg TV that the company doesn&#8217;t plan on investing in new late-stage vaccine trials due to U.S. opposition to immunizations. Intel \u2014 Shares fell 16% after Intel\u00a0reported mixed fourth-quarter results and issued a weak forecast. Intel expects first-quarter revenue will be between $11.7 billion and $12.7 billion, with adjusted profit breaking even. Analysts surveyed by LSEG expected the chipmaker to earn 5 cents per share on $12.51 billion in revenue. Clorox \u2014 The maker of household cleaning products rose almost 3% after it agreed to acquire Gojo Industries , the manufacturer of Purell, for $2.25 billion. Excluding the impact of the purchase, Clorox reaffirmed its 2026 outlook. SLM \u2014 The education lending company also known as Sallie Mae popped nearly 3% after reporting fourth&#8211;quarter earnings of $1.12 per share, topping the FactSet consensus estimate of 94 cents a share. SLM also authorized a new $500 million share repurchase program. Nvidia \u2014 The chipmaker&#8217;s shares rose about 1.6% after CNBC reported that CEO Jensen Huang plans to visit China in the coming days ahead of the mid-February Lunar New Year. The report comes as questions over the U.S. chip giant&#8217;s ability to sell in the Chinese market swirl. Life360 \u2013 Shares rose about 28% after the location-sharing application reported that its monthly active user base grew 20% to 95.8 million users last year. The company also posted better-than-expected preliminary financial results for 2025. Capital One \u2014 The stock dropped more than 6%. The bank announced on Thursday that it agreed to acquire\u00a0startup Brex for $5.15 billion , in a deal consisting of 50% cash and 50% stock. Separately, fourth quarter adjusted earnings came up short against analysts&#8217; estimates, landing at $3.86 per share. The LSEG consensus called for $4.11 per share. Booz Allen Hamilton \u2013 The technology consulting and engineering stock rose more than 7% after it hiked its first-quarter earnings forecast. Booz Allen Hamilton expects adjusted earnings of between $5.95 and $6.15 per share, or higher than its previous guidance of $5.45 to $5.65 per share. The figure also tops the FactSet consensus estimate of $5.62 per share. CSX \u2014 Shares of the railway operator jumped almost 5%. CSX said its intermodal revenue for the fourth quarter came in at $562 million, topping the StreetAccount consensus estimate of $551.2 million. The company also said it expects to see full-year 2026 revenue to rise by low single digits. \u2014 CNBC&#8217;s Nick Wells and Pia Singh contributed reporting.<\/span><\/span><\/span><span class=\"HighlightShare-hidden\" style=\"top:0;left:0\"\/><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Check out the companies making headlines in midday trading. Fortinet \u2014 Shares jumped more than 7% after TD Cowen upgraded the cybersecurity stock to buy from hold, saying rising memory prices won&#8217;t hurt the company as much as some suspect. The firm&#8217;s $100 price target suggests 29% upside ahead. Bausch Health \u2014 The pharmaceutical stock [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3233,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[2373,372,2372,375,371,642,373,2282,238],"class_list":["post-3232","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-bhc","tag-biggest","tag-ftnt","tag-intc","tag-making","tag-midday","tag-moves","tag-mrna","tag-stocks"],"_links":{"self":[{"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/posts\/3232","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/comments?post=3232"}],"version-history":[{"count":0,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/posts\/3232\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/media\/3233"}],"wp:attachment":[{"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/media?parent=3232"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/categories?post=3232"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.finznest.com\/blog\/wp-json\/wp\/v2\/tags?post=3232"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}